Navigation Links
NephroGenex Announces Full Enrollment in New Pyridorin(TM) Clinical Trial - PYR 210
Date:9/9/2009

re expenditures. Mortality rates of ESRD patients can reach 20% annually. Pyridorin(TM) has been awarded Fast Track status by the FDA due to the unmet medical need of this life-threatening disease.

About NephroGenex, Inc.

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have end stage renal disease requiring dialysis, making renal disease one of the costliest illnesses to treat. The Company is developing Pyridorin(TM) (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease. Pyridorin(TM) has demonstrated a significant treatment effect in slowing the progression of diabetic nephropathy in two Phase IIa clinical trials, and has been awarded Fast Track status by the FDA. Pyridorin(TM) is one of only a few drug candidates in advanced clinical trials for diabetic kidney disease, and possesses a distinctly new mechanism of action over currently approved treatments. NephroGenex will seek a partner for Phase III development and commercialization.

    Contact:
    J. Wesley Fox, Ph.D.
    President and CEO
    NephroGenex, Inc.
    (609) 986-1780 phone
    (609) 275-5610 fax
    www.nephrogenex.com
    Email: fox@nephrogenex.com

This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com


'/>"/>
SOURCE NephroGenex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... 19, 2013 A leading symptom of ... put to an end through natural ways, such as ... caused by a number of different underlying problems, the ... because peripheral neuropathy is characterized by damage to the ... part of a larger system, the peripheral nervous system. ...
(Date:5/19/2013)... 20, 2013 May is officially known ... located down under, Platypus Australia, the country's forerunner in ... Monday’ on May 6th to kick off their month ... , With the staggering number of cancer cases ... feverish research to find out what’s causing the epidemic ...
(Date:5/19/2013)... HealthDay Reporter , , SATURDAY, May 18 (HealthDay News) ... Crohn,s disease overcome the fatigue and decreased muscle ... to new research. Extra vitamin D "was ... fatigue, greater quality of life and the ability ... Raftery, a research dietitian and doctoral candidate at ...
(Date:5/19/2013)... 2013 According to a May 14th, 2013 ... are self-conscious about the appearance of certain areas of the ... and exercise fail to tone and tighten these areas. The ... looking to get the firmest body possible (article: ... says Dr. Simon Ourian, Medical Director of Epione Beverly Hills. ...
(Date:5/19/2013)... Coral Springs, FL (PRWEB) May 19, 2013 ... education. It is also a city with one of the ... by ranking it eleventh in their Best Places for Business ... Places for Relocation lists. Omaha is centrally located in ... the stalwarts of industry located there. The producers of ...
Breaking Medicine News(10 mins):Health News:Peripheral Neuropathy Naturally Treatable Through Neuracel's Ultimate Neuropathy Support System 2Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 2Health News:Leading Children’s Sun Protection Swimwear Company Platypus Australia use Skin Cancer Awareness Month to Help Educate Parents 3Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 2Health News:Extra Vitamin D May Ease Crohn's Symptoms, Study Finds 3Health News:Body Firming – The Hottest Treatments Available 2Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2
... Simulation and Education Conference (I/ITSEC) has sold ... County Convention Center in Orlando. Occupying almost 200,000 ... modeling and simulation technology ever. The I/ITSEC ... 2008 at the Orange County Convention Center in ...
... Senior citizens and their caregivers receive two free healthcare organizers from ... information organizers ensure users at home and away receive the best ... medical history. , ... Chicago, IL (PRWEB) November 5, ...
... taken by EarthSearch further reflects their aggressive plans in providing ... around the globe through their integrated GPS/RFID technology. , ... ... -- EarthSearch Communications International, Inc., a leading supplier and developer ...
... 2008--The damaging effects of smoking and smoke exposure can ... noted these negative effects in various stages of infant ... pregnancy can range from higher rates of prematurity to ... new studies and an accompanying editorial soon to be ...
... Foundation Health Plan,Inc., Kaiser Foundation Hospitals and their ... for the quarter ended September,30, 2008, compared to ... KFHP/H,s operating income in the third quarter ... same quarter last year. Financial market,volatility impacted KFHP/H,s ...
... FT. LAUDERDALE, Fla., Nov. 4 After six hours ... old woman and her,husband $3,606,000.00 in a secondhand exposure ... was a result of her secondhand,exposure to asbestos-containing brakes ... no offer to settle the case. Lynda was diagnosed ...
Cached Medicine News:Health News:World's Largest Modeling and Simulation Exhibition Sells Out for '08 2Health News:World's Largest Modeling and Simulation Exhibition Sells Out for '08 3Health News:Seniors in Ogle County, IL Get Free Healthcare Organizers 2Health News:Seniors in Ogle County, IL Get Free Healthcare Organizers 3Health News:EarthSearch Communications International Joins Motorola's Enterprise Mobility Business PartnerSelect Program 2Health News:New evidence strengthens link between cigarette smoke exposure and poor infant health 2Health News:Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results 2Health News:Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results 3Health News:Kaiser Foundation Health Plan and Hospitals Report Third Quarter Results 4
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/17/2013)... May 17, 2013 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will release ... 31, 2013, before market on Tuesday, May 28, 2013.  The ... 2013, at 8:00 a.m. EDT (May 28, 2013 at 8:00 ... and provide an update on recent corporate developments. ...
(Date:5/16/2013)... May 17, 2013 Singapore,s ... Switzerland,s Cytos Biotechnology AG today announced ... Phase 1 clinical trial with their H1N1 influenza vaccine candidate ... In this first Phase 1 clinical trial, the safety and ... protect against H1N1 influenza infection will be evaluated. ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... Four-time NASCAR Cup Series champion Jeff Gordon, known ... he is for his philanthropic activities and tireless support ... the Alabama tornado relief effort through the Jeff Gordon ... clothing for babies and children affected by the destruction. ...
... Genomic Health, Inc. (Nasdaq: GHDX ) ... the American Society of Clinical Oncology (ASCO) Annual Meeting, ... of the Onco type DX® colon cancer Recurrence ... in stage II colon cancer.  The company also will ...
Cached Medicine Technology:Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 2Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 3Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 4Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims 5Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 2Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 3Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 4Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 5Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 6Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 7Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 8Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting 9
... Image Processing Video Camera is our new ... ACMI Image Processing (IP) technology, the IP ... detail. Exciting new features, enhanced image quality, ... an exceptional value. All IP 4.2 cameras ...
... Xenon, Metal Halide and Halogen illumination systems ... design. In addition, Olympus provides the highest ... in conjunction with a lightweight, durable design., ... system, but compatible with all surgical endoscopic ...
... VIBROLITH is an intracorporeal electrokinetic lithotripter ... stones. VIBROLITH guarantees satisfaction in application ... bladder, gall bladder and salivary gland ... in percutaneous applications. Kinetic energy transmitted ...
... Medical Solutions is a comprehensive modular solution ... Urodiagnostics, endourology, lithotripsy, prostate diagnostics and therapy, ... of a urologists responsibilities on a given ... supports the various diagnostic or therapeutic applications, ...
Medicine Products: